An ASCO-Friends Virtual Meeting

When:
April 9, 2021 all-day
2021-04-09T00:00:00-07:00
2021-04-10T00:00:00-07:00
Final Agenda Released

Modernizing Eligibility Criteria in Clinical Trials: How We Can Improve Patient Access and Representation

An ASCO-Friends Virtual Meeting

Friday, April 9, 2021
1:00PM EDT – 2:00PM EDT

Featuring:
Ned Sharpless, Director, National Cancer Institute
Janet Woodcock, Acting Commissioner, U.S. FDA

Register Today
The American Society of Clinical Oncology (ASCO) and Friends of Cancer Research (Friends) are proud to announce a new virtual meeting building on our work to broaden eligibility criteria to make clinical trials more representative. The ASCO-Friends Virtual Meeting, Modernizing Eligibility Criteria in Clinical Trials: How We Can Improve Patient Access and Representation, will bring together experts from across the healthcare sector to discuss the most recent release of the new ASCO-Friends recommendations for modernizing eligibility criteria. Keynotes and panels will discuss how overly restrictive eligibility criteria can impact patient access to trials, trial accrual rates, and limit the ability to generalize the results to the broader population of patients who will ultimately use the drug.

For more information on the project, click HERE. Click through above to view the final agenda and register today.

Follow Us

Contact Us

Friends of Cancer Research
1800 M Street NW Suite 1050 South
Washington, District of Columbia 20036
(202) 944-6700
info@focr.org